RESPONDER STRAINS NONRESPONDER STRAINS
Response to : * (A~ E~) GLPhe k k + (AeE=) PIGEON CYTOCHROME C Fro. l. Biochemieally described products from the I-region of the H-2 complex. A= and A# represent glycoproteins that are encoded in the I-A subregion and are associated on the surface of B lymphocytes of all mouse strains. The Ae and E= glycoproteins are encoded in the I-A and I-E subregions, respectively. Most strains that produce an E= chain express this product in association with the A= chain on the cell surface. Most strains that lack an E= chain produce an A~ chain which can be found in the cell cytoplasm hut not on the cell surface. Strains which have a surface Ae b chain respond to GLPhe, whereas strains with a surface A~ = chain respond to pigeon cytochrome c (responder strains). Strains which lack surface A~ chains do not respond to these antigens (nonresponder strains).
form is found on the cell surface of lymphocytes from strains which synthesize an E~ chain, and is associated with the Ea chain. These findings are summarized in Fig. 1 .
In some cases, both Ir and Lad phenotypes are associated with the surface appearance of the A~:Ea complex (9) (10) (11) . Immune responses to the synthetic polypeptide antigen poly(L-glutamic acid,e-alanine,e-phenylalanine) (GLPHe) 1 correlate with the cell surface appearance of the A~ b chain, whereas immune responses to pigeon cytochrome c correlate with the cell surface appearance of the Ae k chain (10, 11) . In addition, certain clones of alloreactive T cells appear to recognize and are stimulated by the surface form of the ,% chain (12) . Taken together, these observations provide additional support for the notion that Ia antigens in general, and the A~:E~ complex in particular, are products of Ir loci and serve as Lad antigens. Evidence that bolsters this hypothesis is presented here.
We have produced a monoclonal antibody that recognizes a conformational or combinatorial determinant formed by certain A~:E~ complexes. This monoclonal antibody blocks mixed lymphocyte euhures (MLC) directed at the A~:E~ complex and blocks T cell responses to antigens (GLPhe and pigeon cytochrome c) where the response is dependent on interaction between Ir loci that map in the I-A and the I-E 1Abbreviatious used in this paper: B6, C57BL/6; BSA, bovine serum albumin; CB6F~, (BALB/c x C57BL/6)F1; CFA, complete Freund's adjuvant; Con A, concanavalin A; 2-D PAGE, two-dimensional polyacrylamide gel eleetrophoresis; EHAA, Eagle's high amino acid; FACS, fluorescence-activated cell sorter; FCS, fetal calf serum; FITC, fluorescein isothiocyanate; GLPhe, poly(L-glutamic aeid,L-alanine,tphenylalanine); MIg, mouse immunoglobulin; MLC, mixed lymphocyte culture(s); MLR, mixed lymphocyte reaction(s); NMS, normal mouse serum; PEG, polyethylene glycol; PETLES, peritoneal exudate T lymphocyte-enrlched subpopulation; PBS, phosphate-buffered saline; SAS, saturated ammonium sulfate; SDS, sodium dodecyl sulfate; (T,G)-A--L, poly(tyrosine, glutamie acid)-D,L-alanine--L-lysine; TRITC, tetramethyl rhodamine isothiocyanate.
subregions. Thus, these experiments constitute the strongest evidence to date that at least some Ia antigens are products of Lad and Ir loci, and that the Ia loci, Ir loci, and Lad loci are identical.
Materials and Methods
Mice. (BALB/c × C57BL/6)F1 (CB6F 0 mice and the B10.A, B10.A(5R) and (B10 × B 10.A)FI mice used in the peritoneal-exudate-T lymphocyte-enriched subpopulation (PETLES) experiments were obtained from The Jackson Laboratory, Bar Harbor, Maine. All other strains were bred and maintained in our own animal facilities at the Yale University School of Medicine, New Haven, Conn.
Immunization and Fusion Protocol. B10.A(5R) spleen cells, suspended at 5 × 10 6 cells/ml in EHAA medium (17) supplemented with 5% fetal calf serum (FCS), 50 IU/ml penicillin, and 50 '#g/ml streptomycin, were stimulated with 5 #g/ml concanavalin A (Con A) (Pharmacia Fine Chemicals, Inc., Uppsala, Sweden) and 1 × 10 7 cells in complete Freund's adjuvant were injected into the foot pads and peritoneal cavity of BALB/cByJ mice. 3 wk later, the mice were given an intravenous boost of 2 X 107 spleen cells that had been similarly stimulated with Con A in medium that contained 0.5% normal mouse serum (NMS) in place of FCS. 3 d after boosting, their spleens were removed and the cells fused with the nonsecreting myeloma SP 2/0 Agl4 (18) by the procedures of Oi and Herzenberg (19) and Kennett et al. (20) . Spleen and myeloma cells were mixed in a ratio of 1:3 and fused with 50% polyethylene glycol 1500 (PEG). After washing to remove the PEG, the pellet was resuspended to a concentration of I × 10 7 total cells/ml in Dulbecco's modified Eagle's medium (DMEM) with 4.5 g/liter glucose (Grand Island Biological Co., Grand Island, N. Y.) supplemented with 10% NCTC 109 (Microbiological Associates, Walkersville, Md.), 15% FCS, 10 mM Hepes, 1 mM sodium pyruvate, 2 mM L-glutamine, 50 IU/ml penicillin, 50 #g/ml streptomycin, 0.25 #g/ml amphotericin, and Littlefield's (21) concentrations of hypoxanthine (1.0 × 10 -4 M) and thymidine (1.6 × 10 -5 M). 100 #1 of the suspension was added to wells of flat-bottomed microtiter plates (3040; Falcon Labware, Die. of Beeton, Dickinson & Co., Oxnard, Calif.). The hybrids were fed the above media supplemented with aminopterin, 8 × 10 -7 M, the day after fusion and then every 3-4 d until the clones were screened.
Screening Procedures. Supernates from wells with macroscopic clones were screened using a microcytotoxicity assay described previously (22) and by a radioimmunoassay (23) . In the latter method, the binding sites of flexible polyvinyl microtiter plates (Cooke Engineering Co., Alexandria, Va.) were blocked with 1% bovine serum albumin (BSA) in PBS for 1 h at 4°C.
The plates were washed three times with PBS and 50 #l of supernate from the corresponding wells of the culture plate were added. Spleens from the appropriate test strains were removed and the erythrocytes lysed by hypotonic shock. 10 #1 of spleen cells suspended at 5 × 107 cells/ ml in PBS with 5% FCS and 0.1% sodium azide were layered over the supernates and allowed to incubate for 1 h at 4°C. The plates were washed by centrifugation for 2 min at 400 g, flicking out the supernate, filling the wells with PBS followed by a second spin and flick. The pellets were resuspended by vortexing and 25,000 cpm of nSI-protein A (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.) in 50 #1 of PBS was then added. After an additional 1 h at 4°C, the plates were washed six times as above and dried under a heat lamp. Radioautography (24) was performed with Kodak RPR x-ray film (Eastman Kodak Co., Rochester, N. Y.) and an intensifier screen (Cronex Lightning Plus, E. I. DuPont de Nemours & Co., Wilmington, Del.) mounted on the bottom of the plate. The films were developed after a 12-h exposure at -70°C. Positive wells appeared as dark spots against a faint background. To obtain more quantitative information, the wells were cut out and counted in a gamma counter (Uitrogamma 1280; LKB Produkter, Bromma, Sweden).
Purificatzon of Monoclonal Antibody. Cells from one of the wells, termed Y-17, whose supernate was active in both the cytotoxicity and cell-binding screening procedures, were cloned by limiting-dilution. Supernates from all of the wells with subsequent growth showed activity. Cultures were expanded, and cells were frozen for future use or were injected into the peritoneal cavities of Pristane-treated BALB/c mice to generate ascites. Antibody from the ascites fluid was isolated with two successive precipitations using 45% saturated ammonium sulfate followed by dialysis against PBS. (Precipitation with sodium sulfate resulted in the complete loss of antibody activity.)
Determination of Immunoglobulin Class. The antibody fraction obtained above was further purified by IgG class specific elution from a Protein A-Sepharose column (25) . The fractions were monitored with a Uvicord spectrophotometer (LKB Produckter) and collected. They were assayed for activity as described and subjected to Ouchterlony analysis against class-specific goat anti-MIg (Meloy Laboratories Inc., Springfield, Va.). The antibody was found to be complement fixing, protein A binding, and of the IgG2b glass by both protein A-Sepharose chromatography and Ouchterlony analysis. . Antigen-antibody complexes were isolated using Staphylococcus aureus bacterial adsorbent (IgG Sorb; The Enzyme Center, Boston, Mass.). Immunoprecipitated proteins were separated by 2-D PAGE, using nonequilibrium pH gradient electrophoresis (8, 26) for the charge separation in the first-dimension gels. After the second dimension separation by sodium dodecyl sulfate (SDS) slab gel eleetrophoresis, the gels were processed for radioautography using Kodak NS-2T No Screen x-ray film.
MLC. MLC were performed as described previously (27) . Briefly, responder T cells were 
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ANrmEys. Pigeon cytochrome c was purchased from the Sigma Chemical Corporation, St. Louis, Mo. and, subsequently purified by column chromatography on carboxymethyl cellulose to remove contaminants such as polymeric and deamidated forms of the molecule (28) .
GLPhe was originally purchased from Miles-Yeda (Rehovot, Israel) and was the generous CELL CULTURES. The preparation of PETLES and their in vitro culture with antigen are described in detail elsewhere (29) . Briefly, 100 #l of Eagle's high amino acid (EHAA) medium supplemented with 10% FCS and that contained 1 × 105-2 × 105 PETLES were placed in each well of a sterile, U-bottomed microculture plate. To assay lymph node proliferation, draining inguinal and popliteal lymph nodes were aseptically removed from animals 8 d after immunization, teased, screened to form a single cell suspensions, and passed over nylon wool columns in medium that contained 5% FCS. Eluted cells were then plated in 100 pl at 4 × 105 cells/well in flat~bottomed 96-well microtiter plates in EHAA medium supplemented with 10% FCS.
An SAS precipitate of ascites containing Y-17 at 12 mg/ml in 0.1% sodium azide was diluted 1:20 in complete medium supplemented with 10% FCS and then exhaustively dialyzed to remove the azide. To assess blocking of antigen-induced T cell proliferation, 40 #1 of the diluted and dialyzed monoclonal antibody was added to wells, which then received either antigen or medium alone, to achieve a final dilution of Y-17 of 1% (vol:vol). The antigens were then added to the cultures to achieve the following final concentrations in a total vol of 200 #I/well: GLPhe, 50 #g/ml; pigeon cytochrome c, 30 pg/ml; (T,G)-A--L, 50 #g/ml; purified protein To assess the effect of Y-17-plus-complement-induced killing on subsequent antigen-induced proliferation, nylon wool-purified, antigen-primed lymph node cells were incubated in a 1:20 dilution of the monoclone at l0 s cells/ml for 30 min at 4°C. The cells were then washed twice and incubated at the same concentration in a 1:10 dilution of rabbit complement at 37°C for another 30 min. The cells were washed twice again, resuspended in EHAA medium with 10% 5 FCS, and added to microtiter plates at 4 × 10 living cells (assessed by trypan blue dye exclusion) per well, either in the presence of antigen or of medium alone. (Table I) . As judged by both cytotoxicity and radioimmunoassay, Y-17 reacts with immunizing strain B10.A(5R) spleen cells (50% titer, -10 ~) but not recipient strain BALB/c spleen cells (Table I) . Roughly 55% of splenic lymphocytes are lysed in the presence of complement. To determine whether Y-17 reacts with an H-2-or non-H-2-controlled antigen, strain B10.D2 was tested.
Results

Y-17 Reacts with an H-2-controlled Antigen
This strain shares the H-2 a haplotype with BALB/c and the non-H-2 B 10 background with B10.A(5R). Failure of Y-17 to react with B10.D2 maps the locus that controls the determinant to the H-2 complex. (Table I) . Table II (Table III) . At first glance, data presented in Table II suggested ) chains, the cell surface form of free Ea k chains (e.g., A.TFR5), or complexes formed by A~a:E~ a (e.g., BALB/c and B10.D2), or A~P:E, p (e.g., B10.P) chains. (Fig. 2) . Studies of precipitates obtained from CB6Fx hybrids suggested that a third I-region-controlled molecule was precipitated by Y-17. Because relatively low amounts of this molecule were precipitated in heterozygous animals, we examined lysates from homozygous B10.A(5R) and B 10.A animals. A~ b, E, k, and molecules that exhibited a 2-D PAGE pattern indistinguishable from A~ b were precipitated with B10.A(5R) lysates (Fig. 2) . A~ k, E~ k, and molecules that exhibited a 2-D PAGE pattern indistinguishable from A~ k, were precipitated with B10.A lysates (data not shown). No Aa chains were detected in either precipitated lysate. Note that conventionally prepared anti-I-E-subregion sera precipitated only the A~ and E~ chains. The third chain, therefore, does not nonspecifically associate with the A~:E~ complex during the extraction procedure. Although it is clear that this third chain is controlled by an H-2-1inked locus (2-D PAGE patterns from B10.A(5R) and B10.A differ), we are not sure whether the third chain is the A, chain or a new Ia molecule (X). (Table IV and Fig. 3) . Previous studies have shown that anti-I-A or anti-I-E sera react with >95% of splenic B lymphocytes (32) , and that the A,, Ap, E,, and Ae chains are synthesized by these B lymphocytes (33) . In contrast, the maximum percent of spleen cells killed or stained by Y-I 7 was always less than the number of cells killed by conventional anti-I-E reagents, a monoclonal anti-I-A antibody, or stained with FITC-anti-MIg. Representative data for spleen cells from individual mice are shown in Table IV . Furthermore, spleen cells from 5R mice stained with both tetramethyl rhodamine isothiocyanate (TRITC)-anti-mouse #-chain antibody and biotin-conjugated Y-17 plus FITC-conjugated avidin revealed ~20% of #-chain-bearing cells that did not bind Y-17, and occasional (~5%) cells that were Y-17 positive, #-chain negative.
Y-17 Reacts with an I-Region-controlled Determinant (Table lI). As shown in
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In Addition to the Ae and E~ chains, Y-17 Precipitates a Third I-Region-controlled Molecule
Y-17 Reacts with a Subset of B Lymphocytes and with Non-T and Non-B Cells
In addition to cytotoxicity and conventional fluorescence microscopy, a FACS was used to examine anti-Thy-1.2-and-complement-treated spleen cells from a pool of five CB6F1 mice. As shown in Fig. 3 , cells to the right of the arrow were positive by FACS analysis. By these criteria, 3% of the unstained cells had fluorescent intensities above background levels and 82% of the cells labeled with anti-MIg were positive. Only 54% of these same cells that had been stained with Y-17 fell above this fluorescence It is known that some T cells (34) (35) (36) and some spleen cells (which lack both B and T cell markers) (37) react with anti-I-A or anti-I-E subregion sera (38) . In two experiments, column-purified T cells were examined with FITC-anti-Thy-l.2, FITCanti-MIg, and biotin-conjugated Y-17 followed by the addition of FITC-or rhodamine-labeled avidin. In the first experiment, 94% of the cells were Thy-1.2 positive, < 1% Ig positive, and 7% of the total cells were stained with the monoclonal antibody. In the second experiment, in which B cell contamination was 3%, the cells were double-labeled with FITC-anti-Thy-l.2 and a rhodamine-avidin-biotin-Y-17 complex. These cells showed 91% stained only with anti-Thy-l.2, 6% only with Y-17, and none with both conjugates. Y-17 therefore appears to react with a Thy-1.2-negative and Ig-negative set of cells as well as with B cells. We have not detected the antigen on T cells. Fig. 4 and Table V) The appearance of the A~b:E~ k or the Aek:E~ k complex on the cell surface correlates with the ability to respond to GLPhe (10) or pigeon cytoehrome c (11), respectively. Because Y-17 recognizes both of these chain combinations, we examined the ability of Y-17 to block antigen-induced proliferation of PETLES or nylon wool-passed lymph node T cells (Table VI) . The proliferative responses to GLPhe and pigeon cytochrome c were consistently inhibited 80-100% in the presence of 1% Y-17. Y-17 had no effect on the proliferative response to (T,G)-A--L and no significant effect on the medium controls, demonstrating that the antibody was not nonspecifically inhibitory. The proliferative response to PPD was repeatedly inhibited by 10-30% in the presence of Y-17. This result is consistent with our previous blocking studies using anti-Ia.7 sera (38) and suggests that the weak inhibition of the proliferative response to PPD represents the involvement of A~:E~ complexes in the presentation of some determinants on this antigen. In contrast, the complete absence of any significant inhibition of proliferation to (T,G)-A--L, the response to which is under the control of an Ir gene(s) mapping in the I-A subregion, indicates that the A~b:E~ k complex is not involved in the presentation of this antigen.
C57BL/6 Anti-B10.A(5R) and B10.A(4R) Anti-BIO.A(2R) MLC Responses Are Blocked by Y-17 (
Y-17 Inhibits the Response of BIO.A(4R) T Cells to BIO.A(2R) Stimulators
Pretreatment of the responding B I0.A(5R) lymph node cells with a 1:20 dilution of Y-17 plus rabbit complement before culture reduced the proliferative responses to (T,G)-A--L, PPD, and GLPhe by 50-70% (data not shown), suggesting that the specific inhibition seen in the blocking experiments could not be attributed to selective elimination of an antigen-presenting cell subpopulation. Thus, Y-17 inhibits only those antigen-specific proliferative responses controlled by interacting Ir genes that map in the I-A and I-E subregions. These results are the first unequivocal demonstration in the antigen-specific proliferative assay that the inhibitory component in blocking antisera is, in fact, an Ia-specific antibody rather than an antibody directed against either a closely-linked Ir gene product or against the actual T cell receptor for self-Ia (39). These results therefore strongly suggest that Ia molecules are in fact the Ir gene products. Two additional studies show that association of I-A-and I-E-subregion controlled products results in the expression of a serologically detected antigen. Based on straindistribution patterns, the specificity detected by Y-17 is different from that described by Harris and Deloviteh (40) , and similar to that described by LaFuse et al. (Ia.22) [41] . Because preliminary data with certain F1 hybrid combinations suggest that the specificity detected by Y-17 is not Ia.22 (D. B. Murphy. Unpublished observations.), we provisionally designated this specificity Ia.m.44. These observations, coupled with those of Fathman and Hengartner (12) in MLC reveal that numerous antigenic specificities can be generated by the association of two I-region molecules.
The observation that a third I-region-controlled chain (X) is precipitated with Y-17 is intriguing. Because conventionally prepared anti-I-E-subregion sera precipitate only the A~ and E~ chains, the X chain does not nonspecifically associate with Ae:E,, complexes. Based on 2-D-PAGE, the X chain is indistinguishable from the A~ chain. Peptide map analysis of the X chain is in progress to determine whether it is indeed the A~ chain or a new chain. Until this result is obtained, the possible hybrid Ia antigen associations include A~:Ag, Ae:E~, and A~:X. These combinatorial Ia antigens (the number of which would be much amplified in heterozygotes) could have broad implications for immune response gene function.
The two functional studies presented bear on the relationship of I-region linked immune response and Lad genes to Ia antigens. Ia antigens in general, and the A~:E~ complex in particular, are known to be recognized by T cells (5, 6, 34) . Y-17 effectively blocks this recognition, both in response to allogeneic A~:Ea complexes and in response to nominal antigen associated wih self Ae:E, complexes. The appearance of certain Ae:E~ complexes on the cell surface correlates with the ability of T cells from a given strain of mouse to respond to pigeon cytochrome c (11) and with the ability of certain F1 antigen-presenting cells to present GLPhe to B10.A(5R) T cells (10, 42) . These results have been interpreted to indicate that Ia antigens are the lr gene products. The blocking data in the present experiments strongly support this hypothesis.
Previous studies with radiation-induced bone marrow chimeras have suggested that anti-Ia sera inhibit antigen-presenting cell function (but not T lymphocyte function) (43) , and that both Ir gene products must be expressed in the antigen-presenting cell (but neither need be expressed in the T lymphocyte) (44) . The demonstration in this paper that a monoclonal antibody directed against an Ia determinant could inhibit T cell proliferation in an antigen specific manner (i.e., Y-17 blocks the GLPhe response but not the (T,G)-A--L response) suggests that Ia-bearing molecules are indeed the structures whose function is being inhibited at the antigen-presenting cell surface. However, the possibility does remain that Ir and la loci are distinct but closely linked in the genome and that the products of these putative two loci are also closely associated on the cell surface, such that anti-la antibody sterically interferes with Irgene function. The final proof that Ia antigens are indeed Ir gene products must await examination of I-region point mutations in which simultaneous changes in both Ia antigens and Ir-gene function are observed.
Summary
Genetic, biochemical, and functional studies have been performed using a monoclonal antibody, Y-17, directed at a conformational or combinatorial determinant formed by certain Ae:E~ complexes. This determinant appears to be a marker present on a subset of B cells as well as on non-T and non-B spleen cells. Besides A~ and E~ chains, Y-17 precipitates a third chain that is indistinguishable from the A,, chain in two-dimensional gels. This result suggests additional combinatorial complexity in the generation of I-region encoded antigens. Y-17 can inhibit the response of T cells to A~:E~ determinants in mixed lymphocyte cultures. Furthermore, Y-17 blocks antigenspecific T cell proliferative responses to GLPhe and pigeon cytochrome c which have been shown to require the Ae:E~ complex as a restriction element for antigen presentation. These results provide strong evidence for the molecular identity of Ia antigens, Ir-gene products and Lad antigens.
